Brain change trajectories that differentiate the major psychoses

European Journal of Clinical Investigation

Volumn 46, Issue 7, 2016, Pages 658-674

  Liberg, Benny ^a,b   Rahm, Christoffer ^a,b   Panayiotou, Anita ^a,c   Pantelis, Christos ^a,d  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b KAROLINSKA INSTITUTE   (Sweden)

^c SUNSHINE HOSPITAL   (Australia)

^d FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

Author keywords

Bipolar disorder; brain maturation; longitudinal; magnetic resonance imaging; neurodevelopment; psychosis; schizophrenia; trajectories

Indexed keywords

AMYGDALA; ANTERIOR CINGULATE; BIPOLAR DISORDER; BRAIN MATURATION; BRAIN SIZE; FRONTAL CORTEX; GRAY MATTER; HIPPOCAMPUS; HUMAN; INSULA; LATERAL BRAIN VENTRICLE; LONGITUDINAL STUDY; NERVE CELL DIFFERENTIATION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL LOBE; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; TEMPORAL CORTEX; THALAMUS;

EID: 84976541681     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12641     Document Type: Review

References (118)

1. Lichtenstein P, Yip BH, Bjork C, Pawitan Y, Cannon TD, Sullivan PF et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 2009;373:234–9.
2. Maier W, Zobel A, Wagner M. Schizophrenia and bipolar disorder: differences and overlaps. Curr Opin Psychiatry 2006;19:165–70.
3. Tamminga CA, Ivleva EI, Keshavan MS, Pearlson GD, Clementz BA, Witte B et al. Clinical phenotypes of psychosis in the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP). Am J Psychiatry 2013;170:1263–74.
4. Cropley VL, Pantelis C. Using longitudinal imaging to map the ‘relapse signature’ of schizophrenia and other psychoses. Epidemiol Psychiatric Sci 2014;23:219–25.
5. Pantelis C, Yucel M, Bora E, Fornito A, Testa R, Brewer WJ et al. Neurobiological markers of illness onset in psychosis and schizophrenia: The search for a moving target. Neuropsychol Rev 2009;19:385–98.
6. Pantelis C, Yücel M, Wood SJ, Brewer WJ, Fornito A, Berger G et al. Neurobiological Endophenotypes of Psychosis and Schizophrenia: Are there biological markers of illness onset? In: Jackson HJ, McGorry PD, editors. The Recognition and Management of Early Psychosis: A Preventive Approach. Cambridge: Cambridge University Press; 2009: pp 61–80.
7. Kraepelin E, Barclay RM, Robertson GM. Dementia Præcox and Paraphrenia. Edinburgh: E. & S. Livingstone; 1919: 1 pp.
8. Kraepelin E. Manic-Depressive Insanity and Paranoia. New York: Arno Press; 1976: pp. xv, 280 pp.
9. Pantelis C, Yucel M, Wood SJ, Velakoulis D, Sun D, Berger G et al. Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia. Schizophr Bull 2005;31:672–96.
10. Weinberger DR. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 1987;44:660–9.
11. Lewis SW, Murray RM. Obstetric complications, neurodevelopmental deviance, and risk of schizophrenia. J Psychiatr Res 1987;21:413–21.
12. Clouston ST. Lectures on Mental Disease. London: J. & A. Churchill; 1892: 708 pp.
13. O'Connell P, Woodruff PW, Wright I, Jones P, Murray RM. Developmental insanity or dementia praecox: was the wrong concept adopted? Schizophr Res 1997;23:97–106.
14. Lewis SW. Causes of schizophrenia. Lancet 1987;1:1216–17.
15. Rapoport JL, Giedd JN, Gogtay N. Neurodevelopmental model of schizophrenia: update 2012. Mol Psychiatry 2012;17:1228–38.
16. Petanjek Z, Judas M, Simic G, Rasin MR, Uylings HB, Rakic P et al. Extraordinary neoteny of synaptic spines in the human prefrontal cortex. Proc Natl Acad Sci USA 2011;108:13281–6.
17. Walhovd KB, Tamnes CK, Fjell AM. Brain structural maturation and the foundations of cognitive behavioral development. Curr Opin Neurol 2014;27:176–84.
18. Storsve AB, Fjell AM, Tamnes CK, Westlye LT, Overbye K, Aasland HW et al. Differential longitudinal changes in cortical thickness, surface area and volume across the adult life span: regions of accelerating and decelerating change. J Neurosci 2014;34:8488–98.
19. Yeatman JD, Wandell BA, Mezer AA. Lifespan maturation and degeneration of human brain white matter. Nat Commun 2014;5:4932.
20. Schneider MR, DelBello MP, McNamara RK, Strakowski SM, Adler CM. Neuroprogression in bipolar disorder. Bipolar Disord 2012;14:356–74.
21. Bora E, Pantelis C. Meta-analysis of cognitive impairment in first-episode bipolar disorder: comparison with first-episode schizophrenia and healthy controls. Schizophr Bull 2015;41:1095–104.
22. Frank E, Nimgaonkar VL, Phillips ML, Kupfer DJ. All the world's a (clinical) stage: rethinking bipolar disorder from a longitudinal perspective. Mol Psychiatry 2015;20:23–31.
23. Cropley V, Wood SJ, Pantelis C. Brain structural, neurochemical and neuroinflammatory markers of psychosis onset and relapse: is there evidence for a psychosis relapse signature? Int Clin Psychopharmacol 2013;DOI:10.1097/YIC.0b013e32835ab37c. [EPub ahead of print].
24. Angst J. Historical aspects of the dichotomy between manic-depressive disorders and schizophrenia. Schizophr Res 2002;57:5–13.
25. McGorry PD, Purcell R, Hickie IB, Yung AR, Pantelis C, Jackson HJ. Clinical staging: a heuristic model for psychiatry and youth mental health. Med J Aust 2007;187:S40–2.
26. Beer MD. Psychosis: a history of the concept. Compr Psychiatry 1996;37:273–91.
27. Crow TJ. The continuum of psychosis and its implication for the structure of the gene. Br J Psychiatry 1986;149:419–29.
28. Crow TJ. The continuum of psychosis and its genetic origins. The sixty-fifth Maudsley lecture. Br J Psychiatry 1990;156:788–97.
29. Kendell RE, Gourlay J. The clinical distinction between the affective psychoses and schizophrenia. Br J Psychiatry 1970;117:261–6.
30. Hare EH. Variations in the seasonal distribution of births of psychotic patients in England and Wales. Br J Psychiatry 1978;132:155–8.
31. Biederman J, Lerner Y, Belmaker RH. Combination of lithium carbonate and haloperidol in schizo-affective disorder: a controlled study. Arch Gen Psychiatry 1979;36:327–33.
32. Hollister LE, Overall JE, Bennett JL, Kimbell I Jr, Shelton J. Specific therapeutic actions of acetophenazine, perphenazine, and benzquinamide in newly admitted schizophrenic patients. Clin Pharmacol Ther 1967;8:249–55.
33. Powell A, Thomson N, Hall DJ, Wilson L. Parent-child concordance with respect to sex and diagnosis in schizophrenia and manic-depressive psychosis. Br J Psychiatry 1973;123:643–8.
34. Angst J, Felder W, Lohmeyer B. Schizoaffective disorders. Results of a genetic investigation, I. J Affect Disord 1979;1:139–53.
35. Kendler KS, Masterson CC, Davis KL. Psychiatric illness in first-degree relatives of patients with paranoid psychosis, schizophrenia and medical illness. Br J Psychiatry 1985;147:524–31.
36. McDonald C, Bullmore ET, Sham PC, Chitnis X, Wickham H, Bramon E et al. Association of genetic risks for schizophrenia and bipolar disorder with specific and generic brain structural endophenotypes. Arch Gen Psychiatry 2004;61:974–84.
37. Demjaha A, MacCabe JH, Murray RM. How genes and environmental factors determine the different neurodevelopmental trajectories of schizophrenia and bipolar disorder. Schizophr Bull 2012;38:209–14.
38. Kaymaz N, van Os J. Murray et al. (2004) revisited: is bipolar disorder identical to schizophrenia without developmental impairment?. Acta Psychiatr Scand 2009;120:249–52.
39. Bergen SE, O'Dushlaine CT, Ripke S, Lee PH, Ruderfer DM, Akterin S et al. Genome-wide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder. Mol Psychiatry 2012;17:880–6.
40. Sullivan PF, Daly MJ, O'Donovan M. Genetic architectures of psychiatric disorders: the emerging picture and its implications. Nat Rev Genet 2012;13:537–51.
41. McGorry P, Keshavan M, Goldstone S, Amminger P, Allott K, Berk M et al. Biomarkers and clinical staging in psychiatry. World Psychiatry 2014;13:211–23.
42. Nelson B, Yuen HP, Wood SJ, Lin A, Spiliotacopoulos D, Bruxner A et al. Long-term follow-up of a group at ultra high risk (“prodromal”) for psychosis: the PACE 400 study. JAMA Psychiatry 2013;70:793–802.
43. Fusar-Poli P, Bonoldi I, Yung AR, Borgwardt S, Kempton MJ, Valmaggia L et al. Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. Arch Gen Psychiatry 2012;69:220–9.
44. Rahm C, Cullberg J. Diagnostic stability over 3 years in a total group of first-episode psychosis patients. Nord J Psychiatry 2007;61:189–93.
45. Amin S, Singh SP, Brewin J, Jones PB, Medley I, Harrison G. Diagnostic stability of first-episode psychosis. Comparison of ICD-10 and DSM-III-R systems. Br J Psychiatry 1999;175:537–43.
46. Schimmelmann BG, Conus P, Edwards J, McGorry PD, Lambert M. Diagnostic stability 18 months after treatment initiation for first-episode psychosis. J Clin Psychiatry 2005;66:1239–46.
47. Naz B, Bromet EJ, Mojtabai R. Distinguishing between first-admission schizophreniform disorder and schizophrenia. Schizophr Res 2003;62:51–8.
48. Chang WC, Pang SL, Chung DW, Chan SS. Five-year stability of ICD-10 diagnoses among Chinese patients presented with first-episode psychosis in Hong Kong. Schizophr Res 2009;115:351–7.
49. Consoli A, Brunelle J, Bodeau N, Louet E, Deniau E, Perisse D et al. Diagnostic transition towards schizophrenia in adolescents with severe bipolar disorder type I: an 8-year follow-up study. Schizophr Res 2014;159:284–91.
50. Hibar DP, Westlye LT, van ET, Rasmussen J, Leonardo CD, Faskowitz J et al. Subcortical volumetric abnormalities in bipolar disorder. Mol Psychiatry 2016; DOI: 10.1038/mp.2015.227.
51. van Erp TG, Hibar DP, Rasmussen JM, Glahn DC, Pearlson GD, Andreassen OA et al. Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Mol Psychiatry 2016;21:585.
52. Arnone D, Cavanagh J, Gerber D, Lawrie SM, Ebmeier KP, McIntosh AM. Magnetic resonance imaging studies in bipolar disorder and schizophrenia: meta-analysis. Br J Psychiatry 2009;195:194–201.
53. Bora E, Fornito A, Yucel M, Pantelis C. Voxelwise meta-analysis of gray matter abnormalities in bipolar disorder. Biol Psychiatry 2010;67:1097–105.
54. Selvaraj S, Arnone D, Job D, Stanfield A, Farrow TF, Nugent AC et al. Grey matter differences in bipolar disorder: a meta-analysis of voxel-based morphometry studies. Bipolar Disord 2012;14:135–45.
55. Ellison-Wright I, Bullmore E. Anatomy of bipolar disorder and schizophrenia: a meta-analysis. Schizophr Res 2010;117:1–12.
56. Strakowski SM. The Bipolar Brain: Integrating Neuroimaging With Genetics. New York, Oxford: Oxford University Press; 2012: pp. xiii, 280 pp.
57. Velakoulis D, Wood SJ, Wong MT, McGorry PD, Yung A, Phillips L et al. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals. Arch Gen Psychiatry 2006;63:139–49.
58. Berk M, Kapczinski F, Andreazza AC, Dean OM, Giorlando F, Maes M et al. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev 2011;35:804–17.
59. Berk M, Berk L, Dodd S, Cotton S, Macneil C, Daglas R et al. Stage managing bipolar disorder. Bipolar Disord 2014;16:471–7.
60. Lim CS, Baldessarini RJ, Vieta E, Yucel M, Bora E, Sim K. Longitudinal neuroimaging and neuropsychological changes in bipolar disorder patients: review of the evidence. Neurosci Biobehav Rev 2013;37:418–35.
61. Arango C, Rapado-Castro M, Reig S, Castro-Fornieles J, Gonzalez-Pinto A, Otero S et al. Progressive brain changes in children and adolescents with first-episode psychosis. Arch Gen Psychiatry 2012;69:16–26.
62. Vita A, De Peri L, Deste G, Sacchetti E. Progressive loss of cortical gray matter in schizophrenia: a meta-analysis and meta-regression of longitudinal MRI studies. Transl Psychiat 2012;2:e190.
63. Sun D, Phillips L, Velakoulis D, Yung A, McGorry PD, Wood SJ et al. Progressive brain structural changes mapped as psychosis develops in ‘at risk’ individuals. Schizophr Res 2009;108:85–92.
64. Sun D, Stuart GW, Jenkinson M, Wood SJ, McGorry PD, Velakoulis D et al. Brain surface contraction mapped in first-episode schizophrenia: a longitudinal magnetic resonance imaging study. Mol Psychiatry 2009;14:976–86.
65. Gogtay N, Vyas NS, Testa R, Wood SJ, Pantelis C. Age of onset of schizophrenia: perspectives from structural neuroimaging studies. Schizophr Bull 2011;37:504–13.
66. Pantelis C, Wannan C, Bartholomeusz C, Allott K, McGorry P. Cognitive intervention in early psychosis - preserving abilities versus remediating deficits. Curr Opin Behav Sci 2015;4:63–72.
67. Dickey CC, Salisbury DF, Nagy AI, Hirayasu Y, Lee CU, McCarley RW et al. Follow-up MRI study of prefrontal volumes in first-episode psychotic patients. Schizophr Res 2004;71:349–51.
68. Koo MS, Levitt JJ, Salisbury DF, Nakamura M, Shenton ME, McCarley RW. A cross-sectional and longitudinal magnetic resonance imaging study of cingulate gyrus gray matter volume abnormalities in first-episode schizophrenia and first-episode affective psychosis. Arch Gen Psychiatry 2008;65:746–60.
69. Nakamura M, Salisbury DF, Hirayasu Y, Bouix S, Pohl KM, Yoshida T et al. Neocortical gray matter volume in first-episode schizophrenia and first-episode affective psychosis: a cross-sectional and longitudinal MRI study. Biol Psychiatry 2007;62:773–83.
70. Salisbury DF, Kuroki N, Kasai K, Shenton ME, McCarley RW. Progressive and interrelated functional and structural evidence of post-onset brain reduction in schizophrenia. Arch Gen Psychiatry 2007;64:521–9.
71. Lee SH, Niznikiewicz M, Asami T, Otsuka T, Salisbury DF, Shenton ME et al. Initial and progressive gray matter Abnormalities in insular gyrus and temporal pole in first-episode schizophrenia contrasted with first-episode affective psychosis. Schizophr Bull 2016;42:790–801.
72. Takahashi T, Wood SJ, Yung AR, Soulsby B, McGorry PD, Suzuki M et al. Progressive gray matter reduction of the superior temporal gyrus during transition to psychosis. Arch Gen Psychiatry 2009;66:366–76.
73. Farrow TF, Whitford TJ, Williams LM, Gomes L, Harris AW. Diagnosis-related regional gray matter loss over two years in first episode schizophrenia and bipolar disorder. Biol Psychiatry 2005;58:713–23.
74. Dazzan P, Soulsby B, Mechelli A, Wood SJ, Velakoulis D, Phillips LJ et al. Volumetric abnormalities predating the onset of schizophrenia and affective psychoses: an MRI study in subjects at ultrahigh risk of psychosis. Schizophr Bull 2012;38:1083–91.
75. Fornito A, Yucel M, Wood SJ, Bechdolf A, Carter S, Adamson C et al. Anterior cingulate cortex abnormalities associated with a first psychotic episode in bipolar disorder. Br J Psychiatry 2009;194:426–33.
76. Fornito A, Yung AR, Wood SJ, Phillips LJ, Nelson B, Cotton S et al. Anatomic abnormalities of the anterior cingulate cortex before psychosis onset: an MRI study of ultra-high-risk individuals. Biol Psychiatry 2008;64:758–65.
77. Fornito A, Yucel M, Pantelis C. Reconciling neuroimaging and neuropathological findings in schizophrenia and bipolar disorder. Curr Opin Psychiatry 2009;22:312–19.
78. Fornito A, Yucel M, Dean B, Wood SJ, Pantelis C. Anatomical abnormalities of the anterior cingulate cortex in schizophrenia: bridging the gap between neuroimaging and neuropathology. Schizophr Bull 2009;35:973–93.
79. Nieuwenhuys R. The insular cortex: a review. Prog Brain Res 2012;195:123–63.
80. Ellison-Wright I, Glahn DC, Laird AR, Thelen SM, Bullmore E. The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis. Am J Psychiatry 2008;165:1015–23.
81. Takahashi T, Wood SJ, Soulsby B, McGorry PD, Tanino R, Suzuki M et al. Follow-up MRI study of the insular cortex in first-episode psychosis and chronic schizophrenia. Schizophr Res 2009;108:49–56.
82. Takahashi T, Wood SJ, Soulsby B, Tanino R, Wong MT, McGorry PD et al. Diagnostic specificity of the insular cortex abnormalities in first-episode psychotic disorders. Prog Neuropsychopharmacol Biol Psychiatry 2009;33:651–7.
83. Takahashi T, Suzuki M, Zhou SY, Tanino R, Nakamura K, Kawasaki Y et al. A follow-up MRI study of the superior temporal subregions in schizotypal disorder and first-episode schizophrenia. Schizophr Res 2010;119:65–74.
84. Fuster JM. Upper processing stages of the perception-action cycle. Trends Cogn Sci 2004;8:143–5.
85. Paus T. Primate anterior cingulate cortex: where motor control, drive and cognition interface. Nat Rev Neurosci 2001;2:417–24.
86. de Castro-Manglano P, Mechelli A, Soutullo C, Gimenez-Amaya J, Ortuno F, McGuire P. Longitudinal changes in brain structure following the first episode of psychosis. Psychiatry Res 2011;191:166–73.
87. Trzesniak C, Schaufelberger MS, Duran FL, Santos LC, Rosa PG, McGuire PK et al. Longitudinal follow-up of cavum septum pellucidum and adhesio interthalamica alterations in first-episode psychosis: a population-based MRI study. Psychol Med 2012;42:2523–34.
88. Takahashi T, Malhi GS, Wood SJ, Yucel M, Walterfang M, Nakamura K et al. Midline brain abnormalities in established bipolar affective disorder. J Affect Disord 2010;122:301–5.
89. Takahashi T, Yucel M, Yung AR, Wood SJ, Phillips LJ, Berger GE et al. Adhesio interthalamica in individuals at high-risk for developing psychosis and patients with psychotic disorders. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:1708–14.
90. Fornito A, Yucel M, Patti J, Wood SJ, Pantelis C. Mapping grey matter reductions in schizophrenia: an anatomical likelihood estimation analysis of voxel-based morphometry studies. Schizophr Res 2009;108:104–13.
91. Bora E, Pantelis C. Structural trait markers of bipolar disorder: disruption of white matter integrity and localized gray matter abnormalities in anterior fronto-limbic regions. Biol Psychiatry 2011;69:299–300.
92. Mattai AA, Weisinger B, Greenstein D, Stidd R, Clasen L, Miller R et al. Normalization of cortical gray matter deficits in nonpsychotic siblings of patients with childhood-onset schizophrenia. J Am Acad Child Adolesc Psychiatry 2011;50:697–704.
93. Greenstein D, Lenroot R, Clausen L, Chavez A, Vaituzis AC, Tran L et al. Cerebellar development in childhood onset schizophrenia and non-psychotic siblings. Psychiatry Res 2011;193:131–7.
94. Gogtay N, Giedd JN, Lusk L, Hayashi KM, Greenstein D, Vaituzis AC et al. Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci USA 2004;101:8174–9.
95. Thompson PM, Vidal C, Giedd JN, Gochman P, Blumenthal J, Nicolson R et al. Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia. Proc Natl Acad Sci USA 2001;98:11650–5.
96. Douaud G, Smith S, Jenkinson M, Behrens T, Johansen-Berg H, Vickers J et al. Anatomically related grey and white matter abnormalities in adolescent-onset schizophrenia. Brain 2007;130:2375–86.
97. Zalesky A, Pantelis C, Cropley V, Fornito A, Cocchi L, McAdams H et al. Delayed development of brain connectivity in adolescents with schizophrenia and their unaffected siblings. JAMA Psychiatry 2015;72:900–8.
98. Pantelis C, Bartholomeusz CF. Social neuroscience in psychiatry: pathways to discovering neurobiological risk and resilience. World Psychiatry 2014;13:146–7.
99. Gogtay N, Ordonez A, Herman DH, Hayashi KM, Greenstein D, Vaituzis C et al. Dynamic mapping of cortical development before and after the onset of pediatric bipolar illness. J Child Psychol Psychiatry 2007;48:852–62.
100. Whittle S, Lichter R, Dennison M, Vijayakumar N, Schwartz O, Byrne ML et al. Structural brain development and depression onset during adolescence: a prospective longitudinal study. Am J Psychiatry 2014;171:564–71.
101. Whittle S, Simmons JG, Dennison M, Vijayakumar N, Schwartz O, Yap MB et al. Positive parenting predicts the development of adolescent brain structure: a longitudinal study. Dev Cogn Neurosci 2014;8:7–17.
102. Thompson PM, Sowell ER, Gogtay N, Giedd JN, Vidal CN, Hayashi KM et al. Structural MRI and brain development. Int Rev Neurobiol 2005;67:285–323.
103. Huttenlocher PR, Dabholkar AS. Regional differences in synaptogenesis in human cerebral cortex. J Comp Neurol 1997;387:167–78.
104. Seeman P, Bzowej NH, Guan HC, Bergeron C, Becker LE, Reynolds GP et al. Human brain dopamine receptors in children and aging adults. Synapse 1987;1:399–404.
105. Paus T, Zijdenbos A, Worsley K, Collins DL, Blumenthal J, Giedd JN et al. Structural maturation of neural pathways in children and adolescents: in vivo study. Science 1999;283:1908–11.
106. Paus T. Mapping brain maturation and cognitive development during adolescence. Trends Cogn Sci 2005;9:60–8.
107. Klingberg T. Development of a superior frontal-intraparietal network for visuo-spatial working memory. Neuropsychologia 2006;44:2171–7.
108. Ullman H, Almeida R, Klingberg T. Structural maturation and brain activity predict future working memory capacity during childhood development. J Neurosci 2014;34:1592–8.
109. De Luca CR, Wood SJ, Anderson V, Buchanan JA, Proffitt TM, Mahony K et al. Normative data from the CANTAB. I: development of executive function over the lifespan. J Clin Exp Neuropsychol 2003;25:242–54.
110. Khundrakpam BS, Reid A, Brauer J, Carbonell F, Lewis J, Ameis S et al. Developmental changes in organization of structural brain networks. Cereb Cortex 2013;23:2072–85.
111. Sowell ER, Thompson PM, Tessner KD, Toga AW. Mapping continued brain growth and gray matter density reduction in dorsal frontal cortex: inverse relationships during postadolescent brain maturation. J Neurosci 2001;21:8819–29.
112. Giedd JN, Lenroot RK, Shaw P, Lalonde F, Celano M, White S et al. Trajectories of anatomic brain development as a phenotype. Novartis Found Symp 2008;289:101–12; discussion 12-8, 93-5.
113. Cocchi L, Harding IH, Lord A, Pantelis C, Yucel M, Zalesky A. Disruption of structure-function coupling in the schizophrenia connectome. Neuroimage Clin 2014;4:779–87.
114. Yucel M, Lubman DI, Harrison BJ, Fornito A, Allen NB, Wellard RM et al. A combined spectroscopic and functional MRI investigation of the dorsal anterior cingulate region in opiate addiction. Mol Psychiatry 2007;12:611, 91-702.
115. Hill AB. The environment and disease: association or causation? Proc R Soc Med 1965;58:295–300.
116. Skafidas E, Testa R, Zantomio D, Chana G, Everall IP, Pantelis C. Predicting the diagnosis of autism spectrum disorder using gene pathway analysis. Mol Psychiatry 2014;19:504–10.
117. Hawrylycz MJ, Lein ES, Guillozet-Bongaarts AL, Shen EH, Ng L, Miller JA et al. An anatomically comprehensive atlas of the adult human brain transcriptome. Nature 2012;489:391–9.
118. Kang HJ, Kawasawa YI, Cheng F, Zhu Y, Xu X, Li M et al. Spatio-temporal transcriptome of the human brain. Nature 2011;478:483–9.